The in vitro part demonstrated that the two glucagon and Retatrutide specifically diminished ANGPTL3/eight secretion from hepatocytes, which impact was blocked by a glucagon receptor (GCGR) antagonist. These findings suggest that the GCGR agonism of Retatrutide contributes towards the reduction in c